MindFrame Inc.’s LP Device Successfully Utilized in First-in-Human Procedure for the Treatment of Ischemic Stroke

Successful employment of first and only device that can be deployed through microcatheters as small as 10/14 for improved access and increased aspiration

IRVINE, Calif.--()--MindFrame Inc. today announces the successful first-in-human procedures of the MindFrame Capture LP™ low profile device for the treatment of patients suffering from ischemic stroke at Katherinen Hospital in Stuttgart, Germany. Professor Hans Henkes, MD, is helping to lay the groundwork for the clinical use of this advanced technology. Recently awarded a CE mark, MindFrame LP devices are expressly engineered to treat patients suffering from ischemic stroke through microcatheter-based flow restoration and clot extraction, allowing neurointerventionalists to achieve successful procedural and clinical outcomes for patients.

“I am extremely pleased with the performance of the MindFrame LP device,” said Professor Henkes, director of the Clinic for Neuroradiology. “The low profile device allowed me to access tortuous anatomies to remove the thrombus within 20 minutes, from time of deployment to clot aspiration. Restoring blood flow rapidly and removing the clot is vital to preventing irreversible brain damage. The new MindFrame LP device is an innovative option in the treatment of acute ischemic stroke.”

MindFrame Capture LP and MindFrame Flow LP are compatible with any microcatheter 10/14 or greater. With the MindFrame LP devices, clinicians can expect the additional benefit of increased thrombus aspiration when needed, both locally and proximally, as a result of the reduced microcatheter size. The devices offer improved tensile strength and kink resistance for device durability, as well as enhanced trackability for precise placement and control.

“I am excited about the first cases, which are the result of the ability of our scientists and engineers to rapidly respond to the needs of clinicians,” says Ken Charhut, president and CEO of MindFrame Inc. “This milestone underscores our commitment to delivering truly innovative technologies to clinicians around the world in order to provide outstanding patient care.”

MindFrame Capture LP and MindFrame Flow LP devices are not approved for sale in the United States.

For more information about the breakthrough MindFrame Capture LP and MindFrame Flow LP devices, visit www.MindFrameInc.com.

About MindFrame Inc.

MindFrame Inc. is a pioneer in developing optimized technologies for patients experiencing ischemic stroke. The breakthrough MindFrame Therapy Solutions portfolio comprises some of the most advanced device design technology that delivers exceptional rapid flow restoration and clot extraction intended to help clinicians provide improved clinical outcomes for their patients. For more information about these state-of-the-art technologies, visit www.MindFrameInc.com.

Contacts

MindFrame Inc.
Shannon Jacobs, 949.271.1180
shannonj@devicepharm.com

Release Summary

MindFrame Inc. announces successful first-in-human procedures using the MindFrame Capture LP low profile device for treatment of patients suffering from ischemic stroke.

Sharing

Contacts

MindFrame Inc.
Shannon Jacobs, 949.271.1180
shannonj@devicepharm.com